Source: International Congress 2017 – COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Toujani Chekki (Tunis, Tunisia). Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.. 3608

Member's Comments

No comment yet.

Related content which might interest you: Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Mechanisms of Acute Exacerbations in COPD Source: ERS Lung Science Conference 2019 Year: 2019 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 30-day Readmissions After Acute Exacerbations of COPD: How Relevant Are Comorbidities? Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Predictors of exacerbations in patients with bronchiectasis Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Distribution of Blood Eosinophils Among Patients with COPD in Primary Care Source: International Congress 2017 – Management of asthma in different situations Year: 2017 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Exacerbations of Asthma Source: Eur Respir J 2007; 29: 1071 Year: 2007 Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Pattern of Periodontal diseases in Hospitalized Patients with Non-Tubercular Respiratory diseases Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014